Literature DB >> 32855171

Intracrine Testosterone Activation in Human Pancreatic β-Cells Stimulates Insulin Secretion.

Weiwei Xu1, Lina Schiffer2, M M Fahd Qadir1, Yanqing Zhang1, James Hawley3, Paula Mota De Sa1, Brian G Keevil3, Hongju Wu1, Wiebke Arlt2,4, Franck Mauvais-Jarvis5,6.   

Abstract

Testosterone (T) affects β-cell function in men and women. T is a prohormone that undergoes intracrine conversion in target tissues to the potent androgen dihydrotestosterone (DHT) via the enzyme 5α-reductase (5α-R) or to the active estrogen 17β-estradiol (E2) via the aromatase enzyme. Using male and female human pancreas sections, we show that the 5α-R type 1 isoform (SRD5A1) and aromatase are expressed in male and female β-cells. We show that cultured male and female human islets exposed to T produce DHT and downstream metabolites. In these islets, exposure to the 5α-R inhibitors finasteride and dutasteride inhibited T conversion into DHT. We did not detect T conversion into E2 from female islets. However, we detected T conversion into E2 in islets from two out of four male donors. In these donors, exposure to the aromatase inhibitor anastrozole inhibited E2 production. Notably, in cultured male and female islets, T enhanced glucose-stimulated insulin secretion (GSIS). In these islets, exposure to 5α-R inhibitors or the aromatase inhibitor both inhibited T enhancement of GSIS. In conclusion, male and female human islets convert T into DHT and E2 via the intracrine activities of SRD5A1 and aromatase. This process is necessary for T enhancement of GSIS.
© 2020 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32855171      PMCID: PMC7576567          DOI: 10.2337/db20-0228

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  24 in total

1.  Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias.

Authors:  P C Walsh; J D Madden; M J Harrod; J L Goldstein; P C MacDonald; J D Wilson
Journal:  N Engl J Med       Date:  1974-10-31       Impact factor: 91.245

2.  Androgen excess in pancreatic β cells and neurons predisposes female mice to type 2 diabetes.

Authors:  Guadalupe Navarro; Camille Allard; Jamie J Morford; Weiwei Xu; Suhuan Liu; Adrien Jr Molinas; Sierra M Butcher; Nicholas Hf Fine; Manuel Blandino-Rosano; Venkata N Sure; Sangho Yu; Rui Zhang; Heike Münzberg; David A Jacobson; Prasad V Katakam; David J Hodson; Ernesto Bernal-Mizrachi; Andrea Zsombok; Franck Mauvais-Jarvis
Journal:  JCI Insight       Date:  2018-06-21

Review 3.  Importance of oestrogen receptors to preserve functional β-cell mass in diabetes.

Authors:  Joseph P Tiano; Franck Mauvais-Jarvis
Journal:  Nat Rev Endocrinol       Date:  2012-02-14       Impact factor: 43.330

Review 4.  History of aromatase: saga of an important biological mediator and therapeutic target.

Authors:  R J Santen; H Brodie; E R Simpson; P K Siiteri; A Brodie
Journal:  Endocr Rev       Date:  2009-04-23       Impact factor: 19.871

Review 5.  Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole--of clinical importance?

Authors:  J Geisler
Journal:  Br J Cancer       Date:  2011-03-01       Impact factor: 7.640

6.  Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study.

Authors:  Li Wei; Edward Chia-Cheng Lai; Yea-Huei Kao-Yang; Brian R Walker; Thomas M MacDonald; Ruth Andrew
Journal:  BMJ       Date:  2019-04-10

7.  Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival.

Authors:  Suhuan Liu; Cedric Le May; Winifred P S Wong; Robert D Ward; Deborah J Clegg; Marco Marcelli; Kenneth S Korach; Franck Mauvais-Jarvis
Journal:  Diabetes       Date:  2009-07-08       Impact factor: 9.461

8.  Using human genetics to understand the disease impacts of testosterone in men and women.

Authors:  Katherine S Ruth; Felix R Day; Jessica Tyrrell; Deborah J Thompson; Anna Murray; Ken K Ong; Timothy M Frayling; John R B Perry; Andrew R Wood; Anubha Mahajan; Robin N Beaumont; Laura Wittemans; Susan Martin; Alexander S Busch; A Mesut Erzurumluoglu; Benjamin Hollis; Tracy A O'Mara; Mark I McCarthy; Claudia Langenberg; Douglas F Easton; Nicholas J Wareham; Stephen Burgess
Journal:  Nat Med       Date:  2020-02-10       Impact factor: 53.440

Review 9.  MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease.

Authors:  Lina Schiffer; Punith Kempegowda; Wiebke Arlt; Michael W O'Reilly
Journal:  Eur J Endocrinol       Date:  2017-05-31       Impact factor: 6.664

10.  Serum testosterone, sex hormone-binding globulin and sex-specific risk of incident type 2 diabetes in a retrospective primary care cohort.

Authors:  Michael W O'Reilly; Marija Glisic; Balachandran Kumarendran; Anuradhaa Subramanian; Konstantinos N Manolopoulos; Abd A Tahrani; Deepi Keerthy; Taulant Muka; Konstantinos A Toulis; Wasim Hanif; G Neil Thomas; Oscar H Franco; Wiebke Arlt; Krishnarajah Nirantharakumar
Journal:  Clin Endocrinol (Oxf)       Date:  2018-10-23       Impact factor: 3.478

View more
  3 in total

Review 1.  Obesity, type 2 diabetes, and testosterone in ageing men.

Authors:  Gary Wittert; Mathis Grossmann
Journal:  Rev Endocr Metab Disord       Date:  2022-07-14       Impact factor: 9.306

2.  Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study.

Authors:  Balachandran Kumarendran; Michael W O'Reilly; Anuradhaa Subramanian; Dana Šumilo; Konstantinos Toulis; Krishna M Gokhale; Chandrika N Wijeratne; Arri Coomarasamy; Abd A Tahrani; Laurent Azoulay; Wiebke Arlt; Krishnarajah Nirantharakumar
Journal:  Diabetes Care       Date:  2021-10-14       Impact factor: 19.112

Review 3.  Molecular Insulin Actions Are Sexually Dimorphic in Lipid Metabolism.

Authors:  Rosa Isela Ortiz-Huidobro; Myrian Velasco; Carlos Larqué; Rene Escalona; Marcia Hiriart
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-18       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.